Learn More
Medchemexpress LLC Selexipag | 475086-01-2 | 496.62 | 100 MG

Supplier: Medchemexpress LLC HY14870100MG
Selexipag (NS-304) is an orally available and potent agonist for the Prostacyclin (PGI2) receptor (IP receptor). It is also described as an orally available and long-acting IP receptor agonist prodrug, with its active form being MRE-269.
- Orally available and potent agonist for the prostacyclin (PGI2) receptor (IP receptor)
- Long-acting IP receptor agonist prodrug; active form is MRE-269
- Inhibits binding of [3H]Iloprost to human and rat IP receptors
- Increases intracellular cAMP levels in hIP-CHO cells
- Inhibits platelet aggregation in humans and monkeys
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.